These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 8164949

  • 1. Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancer.
    Fuith LC, Czarnecki M, Wachter H, Fuchs D.
    Obstet Gynecol; 1994 May; 83(5 Pt 1):801. PubMed ID: 8164949
    [No Abstract] [Full Text] [Related]

  • 2. Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancer.
    Suzuki M, Ohwada M, Aida I, Tamada T, Hanamura T, Nagatomo M.
    Obstet Gynecol; 1993 Dec; 82(6):946-50. PubMed ID: 8233270
    [Abstract] [Full Text] [Related]

  • 3. [The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients].
    ławicki S, Czygier M, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Pol Merkur Lekarski; 2006 Nov; 21(125):465-8. PubMed ID: 17345841
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary.
    Suzuki M, Kobayashi H, Ohwada M, Terao T, Sato I.
    Gynecol Oncol; 1998 Jan; 68(1):35-7. PubMed ID: 9454657
    [Abstract] [Full Text] [Related]

  • 6. Marker rhythmometry with macrophage-colony stimulating factor (M-CSF).
    Elg S, Halberg E, Ramakrishnan S, Cornélissen G, Haus E, Nicolau G, Carson L, Twiggs L, Long HJ, Halberg F.
    Chronobiologia; 1991 Jan; 18(4):141-52. PubMed ID: 1687728
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML.
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [Abstract] [Full Text] [Related]

  • 8. Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer.
    Gadducci A, Ferdeghini M, Castellani C, Annicchiarico C, Prontera C, Facchini V, Bianchi R, Genazzani AR.
    Gynecol Oncol; 1998 Jul; 70(1):111-4. PubMed ID: 9698485
    [Abstract] [Full Text] [Related]

  • 9. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
    Smith HO, Anderson PS, Kuo DY, Goldberg GL, DeVictoria CL, Boocock CA, Jones JG, Runowicz CD, Stanley ER, Pollard JW.
    Clin Cancer Res; 1995 Mar; 1(3):313-25. PubMed ID: 9815987
    [Abstract] [Full Text] [Related]

  • 10. Circulating macrophage colony stimulating factor as a marker of tumour progression.
    McDermott RS, Deneux L, Mosseri V, Védrenne J, Clough K, Fourquet A, Rodriguez J, Cosset JM, Sastre X, Beuzeboc P, Pouillart P, Scholl SM.
    Eur Cytokine Netw; 2002 Mar; 13(1):121-7. PubMed ID: 11956031
    [Abstract] [Full Text] [Related]

  • 11. [The plasma levels and diagnostic utility of stem cell factor (SCF) and macrophage-colony stimulating factor (M-CSF) in cervical cancer patients].
    Lawicki S, Bedkowska E, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Pol Merkur Lekarski; 2008 Jul; 25(145):38-42. PubMed ID: 18839612
    [Abstract] [Full Text] [Related]

  • 12. Increased serum levels of macrophage colony-stimulating factor in ovarian cancer.
    Xu FJ, Ramakrishnan S, Daly L, Soper JT, Berchuck A, Clarke-Pearson D, Bast RC.
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1356-62. PubMed ID: 1957862
    [Abstract] [Full Text] [Related]

  • 13. Significant correlation of matrix metalloproteinase and macrophage colony-stimulating factor serum concentrations in patients with head and neck cancer.
    Kuropkat C, Duenne AA, Herz U, Renz H, Werner JA.
    Neoplasma; 2004 Nov; 51(5):375-8. PubMed ID: 15640942
    [Abstract] [Full Text] [Related]

  • 14. Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells.
    Lidor YJ, Xu FJ, Martínez-Maza O, Olt GJ, Marks JR, Berchuck A, Ramakrishnan S, Berek JS, Bast RC.
    Exp Cell Res; 1993 Aug; 207(2):332-9. PubMed ID: 8344385
    [Abstract] [Full Text] [Related]

  • 15. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B, Groblewska M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B, Łaszewicz W, Dabrowski A, Szmitkowski M.
    Clin Chim Acta; 2007 May 01; 380(1-2):208-12. PubMed ID: 17368603
    [Abstract] [Full Text] [Related]

  • 16. Inhibin as a diagnostic marker for ovarian cancer.
    Robertson DM, Pruysers E, Jobling T.
    Cancer Lett; 2007 Apr 28; 249(1):14-7. PubMed ID: 17320281
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of macrophage colony-stimulating factor in patients with ovarian cancer undergoing second-look laparotomy.
    Elg SA, Yu Y, Carson LF, Adcock LL, Twiggs LB, Prem KA, Ramakrishnan S.
    Am J Obstet Gynecol; 1992 Jan 28; 166(1 Pt 1):134-7. PubMed ID: 1733183
    [Abstract] [Full Text] [Related]

  • 18. Combination of markers may prove useful in screening for ovarian CA.
    Oncology (Williston Park); 1994 Jun 28; 8(6):79-80. PubMed ID: 8074986
    [No Abstract] [Full Text] [Related]

  • 19. Test of ovarian cancer multiplex xMAP technology panel.
    Vrzalova J, Prazakova M, Novotny Z, Topolcan O, Casova M, Holubec L.
    Anticancer Res; 2009 Feb 28; 29(2):573-6. PubMed ID: 19331205
    [Abstract] [Full Text] [Related]

  • 20. Circulating tumour markers in ovarian tumours.
    von Schlippe M, Rustin GJ.
    Forum (Genova); 2000 Feb 28; 10(4):383-92. PubMed ID: 11535987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.